Literature DB >> 98601

Host-parasite relationships in experimental airborne tuberculosis. VII. Fate of Mycobacterium tuberculosis in primary lung lesions and in primary lesion-free lung tissue infected as a result of bacillemia.

R S Ho, J S Fok, G E Harding, D W Smith.   

Abstract

Evidence suggests that in humans tuberculous disease usually arises at apical or subapical sites in the lungs seeded as a consequence of an early bacillemic phase of the infection. This study examined the fate of bacilli transported via the bloodstream to metastatic sites in the lungs of guinea pigs after aerosol infection with approximately two viable virulent Mycobacterium tuberculosis. The results revealed that, even after logarithmic-phase multiplication of bacilli in primary lesions had been terminated, bacilli seeded via the bloodstream to metastatic sites in the lung were able to multiply. These observations, made in an animal model that mimics the conditions under which tuberculosis develops in human subjects, challenge the relevance of systemic macrophage activation in experimental airborne tuberculosis in guinea pigs.

Entities:  

Mesh:

Year:  1978        PMID: 98601     DOI: 10.1093/infdis/138.2.237

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Magnetic resonance imaging of pulmonary lesions in guinea pigs infected with Mycobacterium tuberculosis.

Authors:  Susan L Kraft; Deanna Dailey; Matthew Kovach; Karen L Stasiak; Jamie Bennett; Christine T McFarland; David N McMurray; Angelo A Izzo; Ian M Orme; Randall J Basaraba
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 2.  Immunity to tuberculosis from the perspective of pathogenesis.

Authors:  E Wiegeshaus; V Balasubramanian; D W Smith
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

3.  Immunogenicity of the Mycobacterium tuberculosis PPE55 (Rv3347c) protein during incipient and clinical tuberculosis.

Authors:  Krishna K Singh; Yuxin Dong; Sai A Patibandla; David N McMurray; Vijay K Arora; Suman Laal
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Effects of diet and genetics on Mycobacterium bovis BCG vaccine efficacy in inbred guinea pigs.

Authors:  M K Cohen; R A Bartow; C L Mintzer; D N McMurray
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

Review 5.  Perspectives on clinical and preclinical testing of new tuberculosis vaccines.

Authors:  Arthur M Dannenberg
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

6.  Cytokine profiles in primary and secondary pulmonary granulomas of Guinea pigs with tuberculosis.

Authors:  Lan H Ly; Murat I Russell; David N McMurray
Journal:  Am J Respir Cell Mol Biol       Date:  2007-11-21       Impact factor: 6.914

7.  Increased expression of host iron-binding proteins precedes iron accumulation and calcification of primary lung lesions in experimental tuberculosis in the guinea pig.

Authors:  Randall J Basaraba; Helle Bielefeldt-Ohmann; Ellie K Eschelbach; Claire Reisenhauer; Airn E Tolnay; Lauren C Taraba; Crystal A Shanley; Erin A Smith; Cathy L Bedwell; Elizabeth A Chlipala; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2007-10-17       Impact factor: 3.131

8.  Assessment of the Efficacy of New Anti-Tuberculosis Drugs.

Authors:  Denis A Mitchison; Geraint R Davies
Journal:  Open Infect Dis J       Date:  2008-12

9.  The contribution of hydrogen peroxide resistance to virulence of Mycobacterium tuberculosis during the first six days after intravenous infection of normal and BCG-vaccinated guinea-pigs.

Authors:  P S Jackett; V R Aber; D A Mitchison; D B Lowrie
Journal:  Br J Exp Pathol       Date:  1981-02

10.  Transcriptional profiling of Mycobacterium tuberculosis replicating ex vivo in blood from HIV- and HIV+ subjects.

Authors:  Michelle B Ryndak; Krishna K Singh; Zhengyu Peng; Susan Zolla-Pazner; Hualin Li; Lu Meng; Suman Laal
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.